Evidence map›Paper›PMID 41816613›Full record

ReviewChemical science2026

Photoluminescence of ligand-protected gold nanoclusters: progress in experimental and theoretical studies.

Kang Li, Pu Wang, Yong Pei

Abstract readReview
In one paragraph

Review in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kang LiDepartment of Chemistry, Key Laboratory of Environmentally Friendly Chemistry and Applications of Ministry of Education, Xiangtan University Hunan Province 411105 China ypei2@xtu.edu.cn 90wangpu@xtu.edu.cn.
Pu WangDepartment of Chemistry, Key Laboratory of Environmentally Friendly Chemistry and Applications of Ministry of Education, Xiangtan University Hunan Province 411105 China ypei2@xtu.edu.cn 90wangpu@xtu.edu.cn.ORCID https://orcid.org/0000-0002-6903-2874
Yong PeiDepartment of Chemistry, Key Laboratory of Environmentally Friendly Chemistry and Applications of Ministry of Education, Xiangtan University Hunan Province 411105 China ypei2@xtu.edu.cn 90wangpu@xtu.edu.cn.ORCID https://orcid.org/0000-0003-0585-2045

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ligand-protected gold nanoclusters, with their small sizes and atomically precise structures, exhibit unique photophysical properties that position them as promising candidates for applications in bioimaging, sensing, and optoelectronics. However, except for a few ligand-protected gold nanoclusters, their photoluminescence quantum yield (PLQY) is still relatively low, and the underlying emission mechanisms are not yet fully elucidated. This review highlights recent experimental and theoretical advances aimed at enhancing and elucidating the photoluminescence (PL) mechanisms of ligand-protected gold nanoclusters. Experimentally, strategies such as heterometallic doping, ligand engineering, and structural rigidification have been employed to promote radiative transitions and suppress nonradiative decay, resulting in substantial improvements in PLQY. Theoretically, methods including density functional theory (DFT), time-dependent density functional theory (TDDFT), and nonadiabatic molecular dynamics (NA-MD) have provided important insights into the PL origin, emission pathways, and excited-state dynamics of ligand-protected gold nanoclusters. These advances will deepen our understanding of structure-property relationships in ligand-protected gold nanoclusters and pave the way for the rational design of highly emissive gold nanoclusters.

Identifiers

PMID41816613
PMCPMC12973312

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.